This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Id Pharma Co., Ltd., Ip2ipo Innovations Limited. Active years: 2020.
Company Filing History:
1 out of 9 
1 out of 52 Years Active: 2020
Title: Lee Adrian Davies: Innovator in Gene Therapy
Introduction
Lee Adrian Davies is a notable inventor based in Oxfordshire, GB. He has made significant contributions to the field of gene therapy, particularly through his innovative work on lentiviral vectors. His research focuses on developing methods to treat respiratory tract diseases, showcasing his commitment to advancing medical science.
Latest Patents
Davies holds a patent related to lentiviral gene transfer vectors. This invention involves vectors pseudotyped with hemagglutinin-neuraminidase (HN) and fusion (F) proteins from a respiratory paramyxovirus. The patent includes a promoter and a transgene, along with methods for creating these vectors. The application of this invention is particularly relevant for gene therapy aimed at treating respiratory tract diseases such as Cystic Fibrosis (CF).
Career Highlights
Throughout his career, Lee Adrian Davies has worked with various companies, including Ip2ipo Innovations Limited and Id Pharma Co., Ltd. His experience in these organizations has contributed to his expertise in the field of gene therapy and vector development.
Collaborations
Davies has collaborated with notable individuals in his field, including Eric Walter Frederick Wolfgang Alton and Uta Griesenbach. Their joint efforts have furthered research and development in gene therapy applications.
Conclusion
Lee Adrian Davies is a pioneering inventor whose work in lentiviral vectors has the potential to transform gene therapy for respiratory diseases. His contributions to the field highlight the importance of innovation in medical research and treatment.